Abstract
The worldwide epidemic scale of Diabetes mellitus (DM) has been underestimated for a long time. Currently every 10 seconds one patient dies of diabetes-related pathologies. Given the high risk and prevalence of secondary complications as well as individual predisposition to target organ injury, DM is one of the best examples for the application of predictive diagnostics aimed at preventive measures and personalized treatment. Generally, there are three levels desirable for pre- and Diabetes care:
1st level: prediction of the predisposition early in childhood
2nd level: prediction of early/premature aging and pre-stages of Diabetes
3rd level: prediction of Diabetes-related complications - cardiovascular, neurodegenerative and cancer diseases frequently developed in Diabetics.
Predictive diagnosis is considered as the basis for targeted preventive measures and consequent development of individualized treatment approaches. Communication among the professionals e.g. healthcare providers, policy-makers, educators, obligatorily involved in the overall process to improve (pre)Diabetes care is of paramount importance.
Keywords: Diabetes mellitus, morbidity, &, mortality, cardiovascular / Cancer / Neurodegenrative complications, socioeconomical burden, healthcare, predictive diagnosis, preventive measures, personalized medicine, healthcare providers, policymakers
Current Diabetes Reviews
Title: Advanced Diabetes Care: Three Levels of Prediction, Prevention & Personalized Treatment
Volume: 6 Issue: 1
Author(s): Olga Golubnitschaja
Affiliation:
Keywords: Diabetes mellitus, morbidity, &, mortality, cardiovascular / Cancer / Neurodegenrative complications, socioeconomical burden, healthcare, predictive diagnosis, preventive measures, personalized medicine, healthcare providers, policymakers
Abstract: The worldwide epidemic scale of Diabetes mellitus (DM) has been underestimated for a long time. Currently every 10 seconds one patient dies of diabetes-related pathologies. Given the high risk and prevalence of secondary complications as well as individual predisposition to target organ injury, DM is one of the best examples for the application of predictive diagnostics aimed at preventive measures and personalized treatment. Generally, there are three levels desirable for pre- and Diabetes care:
1st level: prediction of the predisposition early in childhood
2nd level: prediction of early/premature aging and pre-stages of Diabetes
3rd level: prediction of Diabetes-related complications - cardiovascular, neurodegenerative and cancer diseases frequently developed in Diabetics.
Predictive diagnosis is considered as the basis for targeted preventive measures and consequent development of individualized treatment approaches. Communication among the professionals e.g. healthcare providers, policy-makers, educators, obligatorily involved in the overall process to improve (pre)Diabetes care is of paramount importance.
Export Options
About this article
Cite this article as:
Golubnitschaja Olga, Advanced Diabetes Care: Three Levels of Prediction, Prevention & Personalized Treatment, Current Diabetes Reviews 2010; 6 (1) . https://dx.doi.org/10.2174/157339910790442637
DOI https://dx.doi.org/10.2174/157339910790442637 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of microRNAs in the Initiation and Progression of Stable Atheromatous Plaque
Current Pharmaceutical Design Synthesis of Iminosugars from Tetroses
Current Organic Synthesis A Partial Failure of Membrane Protein Turnover May Cause Alzheimers Disease: A New Hypothesis
Current Alzheimer Research The Influence of Genetic Variations and Drug Interactions Based on Metabolism of Antidepressants and Anticonvulsants
Current Drug Metabolism Etiology of the Metabolic Syndrome
Current Cardiology Reviews Mucoadhesive Polymers for Delivery of Drugs to the Oral Cavity
Recent Patents on Drug Delivery & Formulation Clinical, Molecular, and Genetic Characteristics of PAPA Syndrome: A Review
Current Genomics HPLC Stability Indicating Assay Method for Metformin Hydrochloride in Bulk Drug and Tablets and Cytotoxicity of Degradation Products
Current Pharmaceutical Analysis The Cardiovascular Effects of Metformin: Further Reasons to Consider An Old Drug as a Cornerstone in the Therapy of Type 2 Diabetes Mellitus
Current Vascular Pharmacology Gestational Diabetes and the Metabolic Syndrome: Can Obesity and Small, Dense Low Density Lipoproteins be Key Mediators of this Association?
Current Pharmaceutical Biotechnology Next Steps in Alzheimers Disease Research: Interaction between Epidemiology and Basic Science
Current Alzheimer Research The Role of AGEs and AGE Inhibitors in Diabetic Cardiovascular Disease
Current Drug Targets Nephro-Protective Effect of Cortex Lycii Radicis Extracts in Streptozotocin- Induced Diabetic Rats
Current Signal Transduction Therapy PDE-5 Inhibitors: Clinical Points
Current Drug Targets Is Whole-Body Thermoregulatory Function Impaired in Type 1 Diabetes Mellitus?
Current Diabetes Reviews Exploring the Cardio-metabolic Relevance of T-cadherin: A Pleiotropic Adiponectin Receptor
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Parathyroid Hormone-Related Protein (PTHrP) in the Pathophysiology of Diabetes Mellitus
Mini-Reviews in Medicinal Chemistry A Link Between Hypertension and Atrial Fibrillation: Methods of Treatment and Prevention
Current Vascular Pharmacology Short- and Long-Term Survival of Nonsurgical Intensive Care Patients and its Relation to Diagnosis, Severity of Disease, Age and Comorbidities
Current Aging Science Natural and Nanotechnology Based Treatment: An Alternative Approach to Psoriasis
Current Nanomedicine